期刊文献+

坤泰胶囊对围绝经期女性心血管病危险因素的影响 被引量:4

Effects of Kun-Tai capsule on the cardiovascular risk factors in menopausal women
下载PDF
导出
摘要 目的:探讨坤泰胶囊对围绝经期女性心血管病危险因素的影响。方法选择2013年1~3月就诊于我院妇科门诊的围绝经期妇女60例,随机分为试验组(坤泰胶囊,30例)和对照组(维生素E,30例),治疗6个月,分别于治疗前及治疗后3个月和6个月测量治疗前后的Kupperman更年期指数(KMI)、体重、超敏C反应蛋白(hs-CRP)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)及糖化血红蛋白(HbA1c),并记录治疗期间用药相关并发症。结果采用意向性分析(Intention-to-treat,ITT)表述结果。与对照组及治疗前比较,服用坤泰胶囊均可有效改善女性围绝经期症状,KMI较治疗前显著降低(P〈0.05);持续应用至6个月,可有效降低hs-CRP水平(P〈0.05);且hs-CRP降低的程度与KMI的改善情况具有一定的相关性(r=0.64,P〈0.05)。但坤泰胶囊对BMI、血脂和血糖控制情况的改善则无明显优势(P〉0.05)。坤泰胶囊治疗期间,乳房胀痛和头晕、头痛等是较常见的不良反应。结论坤泰胶囊能显著改善女性围绝经期症状,长期应用可降低体内炎症反应,可能有益于减少心血管不良事件的发生。 Objective To explore the potential effects of Kun-Tai capsule on the cardiovascular risk factors in climacteric women. Methods Sixty menopausal women of Gynaecology Outpatient Department in our hospital from January 2013 to March 2013 were enrolled. Patients were randomly divided into experimental group (Kun-Tai capsule, KT group, n=30) and control group (vitamin E as placebo, PA group, n=30). The treatment lasted for 6 months and Kupperman index (KMI) and weight of patients were recorded and blood samples were collected to moni-tor the changes of hs-CRP, LDL-C, HDL-C and HbA1c at pre-treatment, 3 months and 6 months after the treatment. Additionally, drug related adverse events were recorded during the treatment. Results All results were calculated and explained with intention-to-treat (ITT) sample. Compared with PA group and the baseline of KT group, Kun-Tai capsule significantly improved the menopausal symptoms with a markedly decreased of KMI at 3 months after treat-ment (P〈0.05). Besides, hs-CRP was significantly decreased when the treatment continued to 6 months (P〈0.05). In-terestingly, the correlation of the change of hs-CRP and KMI was observed (r=0.64, P〈0.05). However, no more marked improvements of BMI, LDL-C, HDL-C, and HbA1c were detected (P〉0.05). Breasts distending pain, dizzi-ness and headache were the common adverse events during the treatment. Conclusion Treatment using Kun-Tai capsule can improve the menopausal symptoms and the lower hs-CRP level, suggesting a cardiovascular protective effect might benefit the patients with a long-term treatment.
出处 《海南医学》 CAS 2014年第10期1447-1450,共4页 Hainan Medical Journal
关键词 坤泰胶囊 围绝经期 心血管病 危险因素 Kun-Tai capsule Climacteric Cardiovascular disease Risk factors
  • 相关文献

参考文献14

二级参考文献35

  • 1张绍芬,刘旸,谢倩,毕崇萍,朱慧庭,哈灵侠,蒋竞,夏贤,周抗美,刘建华.更年宁心胶囊对更年期大鼠卵巢及子宫内膜组织形态的影响[J].中华老年医学杂志,2004,23(9):648-651. 被引量:44
  • 2陈蓉,陈继英,林守清,柴丽娜,李冬梅,张颖,姜颖,陈凤领.坤泰胶囊治疗更年期综合征的作用——随机、双盲平行对照临床研究[J].中国妇幼保健,2005,20(14):1751-1754. 被引量:41
  • 3陈蓉,林守清,杨欣,栾艳秋,陈继英,柴丽娜,张颖,姜颖.坤泰胶囊治疗妇女更年期综合征的临床研究[J].中国新药杂志,2005,14(12):1472-1476. 被引量:52
  • 4王绍海,林守清,金敏娟,桂启芳,陈凤龄.绝经后妇女应用不同性激素治疗方案的效果观察[J].中国实用妇科与产科杂志,2007,23(3):184-188. 被引量:20
  • 5Rossouv JE, Prentice RE, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA,2007.297(13):1465-1477. 被引量:1
  • 6Collins P Rosano G, Casey C, et al. Management of cardiovascular risk in the peri-menopausal women: a consensus statement of European cardiologists and gynaecologists. Eur Heart J,2007.28(16) :2028-2040. 被引量:1
  • 7Ichikawa J, Sumino H, Ichikawa S, et al. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens,2006 , 19(7) :744-749. 被引量:1
  • 8Odmark IS, Carlstrom K, Jonsson B, et al. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: effects on carbohydrate metabolism and serum sex hormone-binding globulin. Maturitas,2006,53(1) :89-96. 被引量:1
  • 9The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women, the postmenopausal estrogen/ progestin interventions (PEPI) trial. JAMA, 1995, 273 (3) : 199-208. 被引量:1
  • 10Kuller LH. Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative. Arterioscler Thromb Vase Biol, 2003.23(1) :11-16. 被引量:1

共引文献124

同被引文献36

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部